Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 91Carcinoma, Non-Small-Cell Lung 53Lung Neoplasms 22Hodgkin Disease 15Recurrence 11Lymphoma 10Neoplasm Metastasis 9Prostatic Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 6Sarcoma 4Rhabdomyosarcoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Adenocarcinoma of Lung 4Multiple Myeloma 3Mesothelioma, Malignant 3Mesothelioma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Melanoma 2Lymphoma, Large-Cell, Anaplastic 2HER2-negative Breast Cancer 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Brain Neoplasms 2Advanced Breast Cancer 2

Interventions

Fulvestrant 8olaparib 4Capecitabine 4pyrotinib 3Docetaxel 3toripalimab 2Vinorelbine 2Trastuzumab 2Letrozole 2Injections 2Goserelin 2Alpelisib 2vandetanib 1trastuzumab deruxtecan 1talazoparib 1sacituzumab govitecan 1pembrolizumab 1neratinib 1liposomal doxorubicin 1exemestane 1eribulin 1dalpiciclib 1ceralasertib 1cediranib 1capivasertib 1abemaciclib 1Tablets 1Paclitaxel 1Moxifloxacin 1Lead 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Advanced Breast Cancer × Vinorelbine × Clear all
NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT04304352 2023-06-28

VEX

European Institute of Oncology

Phase 2 Unknown
162 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡